相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Glucosylsphingosine but not Saposin C, is the target antigen in Gaucher disease-associated gammopathy
Shiny Nair et al.
MOLECULAR GENETICS AND METABOLISM (2020)
Activity-Based Imaging of Acid Ceramidase in Living Cells
Yadira F. Ordonez et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
MYELIN IN THE CENTRAL NERVOUS SYSTEM: STRUCTURE, FUNCTION, AND PATHOLOGY
Christine Stadelmann et al.
PHYSIOLOGICAL REVIEWS (2019)
Role of β-glucosidase 2 in aberrant glycosphingolipid metabolism: model of glucocerebrosidase deficiency in zebrafish[S]
Lindsey T. Lelieveld et al.
JOURNAL OF LIPID RESEARCH (2019)
Genetic ablation of acid ceramidase in Krabbe disease confirms the psychosine hypothesis and identifies a new therapeutic target
Yedda Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Drosophila melanogaster Mutated in its GBA1b Ortholog Recapitulates Neuronopathic Gaucher Disease
Or Cabasso et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Lyso-Gb3 modulates the gut microbiota and decreases butyrate production
John-Jairo Aguilera-Correa et al.
SCIENTIFIC REPORTS (2019)
Saposin C is a frequent target of paraproteins in Gaucher disease-associated MGUS/multiple myeloma
Klaus-Dieter Preuss et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Glycosphingolipids and lysosomal storage disorders as illustrated by gaucher disease
Johannes M. F. G. Aerts et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2019)
Glycosphingolipids and Infection. Potential New Therapeutic Avenues
Johannes M. F. G. Aerts et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Reduced cerebral vascularization in experimental neuronopathic Gaucher disease
Nicholas J. C. Smith et al.
JOURNAL OF PATHOLOGY (2018)
Sphingolipids and their metabolism in physiology and disease
Yusuf A. Hannun et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Emerging concepts of ganglioside metabolism
Roger Sandhoff et al.
FEBS LETTERS (2018)
Acid ceramidase inhibition ameliorates α-synuclein accumulation upon loss of GBA1 function
Myung Jong Kim et al.
HUMAN MOLECULAR GENETICS (2018)
Dissociation of globotriaosylceramide and impaired endothelial function in α-galactosidase-A deficient EA.hy926 cells
Nayiri Kaissarian et al.
MOLECULAR GENETICS AND METABOLISM (2018)
Glucosylsphingosine Causes Hematological and Visceral Changes in Mice-Evidence for a Pathophysiological Role in Gaucher Disease
Jan Lukas et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease
Yumiko V. Taguchi et al.
JOURNAL OF NEUROSCIENCE (2017)
Contribution of inflammatory pathways to Fabry disease pathogenesis
Paula Rozenfeld et al.
MOLECULAR GENETICS AND METABOLISM (2017)
Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease
Manoj K. Pandey et al.
NATURE (2017)
Immune dysfunction in Niemann-Pick disease type C
Nick Platt et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidases
Maria J. Ferraz et al.
FEBS LETTERS (2016)
Glucosylated cholesterol in mammalian cells and tissues: formation and degradation by multiple cellular β-glucosidases
Andre R. A. Marques et al.
JOURNAL OF LIPID RESEARCH (2016)
Neuroimmune Mechanisms in
Gregory B. Potter et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2016)
Lyso-glycosphingolipid abnormalities in different murine models of lysosomal storage disorders
Maria J. Ferraz et al.
MOLECULAR GENETICS AND METABOLISM (2016)
Glycosphingolipid analysis in a naturally occurring ovine model of acute neuronopathic Gaucher disease
Litsa Karageorgos et al.
NEUROBIOLOGY OF DISEASE (2016)
Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma
Shiny Nair et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Biochemical response to substrate reduction therapy versus enzyme replacement therapy in Gaucher disease type 1 patients
Bouwien E. Smid et al.
ORPHANET JOURNAL OF RARE DISEASES (2016)
Elevation of glycoprotein nonmetastatic melanoma protein B in type 1 Gaucher disease patients and mouse models
Gertjan Kramer et al.
FEBS OPEN BIO (2016)
Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study
Aya Narita et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Development of an acid ceramidase activity-based probe
Cecile M. J. Ouairy et al.
CHEMICAL COMMUNICATIONS (2015)
Spinal muscular atrophy associated with progressive myoclonic epilepsy: A rare condition caused by mutations in ASAH1
Guido Rubboli et al.
EPILEPSIA (2015)
Lyso-Gb3 activates Notch1 in human podocytes
Maria D. Sanchez-Nino et al.
HUMAN MOLECULAR GENETICS (2015)
Quantification of sulfatides and lysosulfatides in tissues and body fluids by liquid chromatography-tandem mass spectrometry
Mina Mirzaian et al.
JOURNAL OF LIPID RESEARCH (2015)
Lentiviral Gene Therapy Using Cellular Promoters Cures Type 1 Gaucher Disease in Mice
Maria Dahl et al.
MOLECULAR THERAPY (2015)
Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammation
Shiny Nair et al.
BLOOD (2015)
Inhibition of UDP-glucosylceramide synthase in mice prevents Gaucher disease-associated B-cell malignancy
Elena V. Pavlova et al.
JOURNAL OF PATHOLOGY (2015)
Reducing GBA2 Activity Ameliorates Neuropathology in Niemann-Pick Type C Mice
Andre R. A. Marques et al.
PLOS ONE (2015)
Sulfatide levels correlate with severity of neuropathy in metachromatic leukodystrophy
Christine I. Dali et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Gaucher disease and Fabry disease: New markers and insights in pathophysiology for two distinct glycosphingolipidoses
Maria J. Ferraz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2014)
Glucocerebrosidase is shaking up the synucleinopathies
Marina Siebert et al.
BRAIN (2014)
IL-13Rα2-bearing, type II NKT cells reactive to sulfatide self-antigen populate the mucosa of ulcerative colitis
Ivan J. Fuss et al.
GUT (2014)
Sphingolipid lysosomal storage disorders
Frances M. Platt
NATURE (2014)
Glycosphingolipids: synthesis and functions
Giovanni D'Angelo et al.
FEBS JOURNAL (2013)
The Sphingolipid Psychosine Inhibits Fast Axonal Transport in Krabbe Disease by Activation of GSK3β and Deregulation of Molecular Motors
Ludovico Cantuti Castelvetri et al.
JOURNAL OF NEUROSCIENCE (2013)
Gangliosides and Gangliosidoses: Principles of Molecular and Metabolic Pathogenesis
Konrad Sandhoff et al.
JOURNAL OF NEUROSCIENCE (2013)
Fabry disease peripheral blood immune cells release inflammatory cytokines: Role of globotriaosylceramide
Pablo N. De Francesco et al.
MOLECULAR GENETICS AND METABOLISM (2013)
Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity
Natalia Realini et al.
SCIENTIFIC REPORTS (2013)
Ceramide synthases at the centre of sphingolipid metabolism and biology
Thomas D. Mullen et al.
BIOCHEMICAL JOURNAL (2012)
Invariant natural killer T cells are not affected by lysosomal storage in patients with Niemann-Pick disease type C
Anneliese O. Speak et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Identification of novel glycolipid ligands activating a sulfatide-reactive, CD1d-restricted, type II natural killer T lymphocyte
Sara Rhost et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Ex Vivo and in Vivo Effects of Isofagomine on Acid β-Glucosidase Variants and Substrate Levels in Gaucher Disease
Ying Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The link between the GBA gene and parkinsonism
Ellen Sidransky et al.
LANCET NEUROLOGY (2012)
The Hypothesis on Function of Glycosphingolipids and ABO Blood Groups Revisited
Jerzy Koscielak
NEUROCHEMICAL RESEARCH (2012)
CD4 and CD8 T cells require different membrane gangliosides for activation
Masakazu Nagafuku et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Sulfatide-activated type II NKT cells prevent allergic airway inflammation by inhibiting type I NKT cell function in a mouse model of asthma
Guqin Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2011)
Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response
Nick Dekker et al.
BLOOD (2011)
Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics
Alfred H. Merrill
CHEMICAL REVIEWS (2011)
Sulfatide-Mediated Activation of Type II Natural Killer T Cells Prevents Hepatic Ischemic Reperfusion Injury In Mice
Philomena Arrenberg et al.
GASTROENTEROLOGY (2011)
Accumulation of lysosulfatide in the brain of arylsulfatase A-deficient mice
Maria Blomqvist et al.
LIPIDS IN HEALTH AND DISEASE (2011)
Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy
Maria D. Sanchez-Nino et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Lyso-GM2 Ganglioside: A Possible Biomarker of Tay-Sachs Disease and Sandhoff Disease
Takashi Kodama et al.
PLOS ONE (2011)
Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits
Ying Sun et al.
HUMAN MOLECULAR GENETICS (2010)
Hereditary Sensory Neuropathy Type 1 Is Caused by the Accumulation of Two Neurotoxic Sphingolipids
Anke Penno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Vasculopathy in patients with Fabry disease: Current controversies and research directions
S. M. Rombach et al.
MOLECULAR GENETICS AND METABOLISM (2010)
Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage
Pramod K. Mistry et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells
Maria Blomqvist et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Bioactive sphingolipids: metabolism and function
Nana Bartke et al.
JOURNAL OF LIPID RESEARCH (2009)
Psychosine Accumulates in Membrane Microdomains in the Brain of Krabbe Patients, Disrupting the Raft Architecture
Adam B. White et al.
JOURNAL OF NEUROSCIENCE (2009)
Lysosulfatide Regulates the Motility of a Neural Precursor Cell Line Via Calcium-mediated Process Collapse
M. Hans et al.
NEUROCHEMICAL RESEARCH (2009)
The sphingolipid salvage pathway in ceramide metabolism and signaling
Kazuyuki Kitatani et al.
CELLULAR SIGNALLING (2008)
The role of AMPK in psychosine mediated effects on oligodendrocytes and astrocytes: Implication for Krabbe Disease
Shailendra Giri et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Principles of bioactive lipid signalling: lessons from sphingolipids
Yusuf A. Hannun et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Elevated globotriaosylsphingosine is a hallmark of Fabry disease
Johannes M. Aerts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Psychosine-induced apoptosis and cytokine activation in immune peripheral cells of Krabbe patients
Patrizia Formichi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Increased TNF-α production by peripheral blood mononuclear cells in patients with Krabbe's disease:: effect of psychosine
A. L. Pasqui et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)
Sulfatide storage in neurons causes hyperexcitability and axonal degeneration in a mouse model of metachromatic leukodystrophy
Matthias Eckhardt et al.
JOURNAL OF NEUROSCIENCE (2007)
Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance
Kazuya Kabayama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases
Stephan D. Gadola et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Cardiac and vascular hypertrophy in Fabry disease: Evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition
F Barbey et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase
MA Simpson et al.
NATURE GENETICS (2004)
Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention
RG Boot et al.
BLOOD (2004)
Glucosylceramide and glucosylsphingosine modulate calcium mobilization from brain microsomes via different mechanisms
E Lloyd-Evans et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Toxicity of glucosylsphingosine (glucopsychosine) to cultured neuronal cells: a model system for assessing neuronal damage in Gaucher disease type 2 and 3
UH Schueler et al.
NEUROBIOLOGY OF DISEASE (2003)
Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy
FM Platt et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2001)
Inhibition of cytokinesis by a lipid metabolite, psychosine
T Kanazawa et al.
JOURNAL OF CELL BIOLOGY (2000)
分享论文
